- Home
- JYNT vs SEER Comparison
JYNT vs SEER Comparison
Compare JYNT & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JYNT | SEER |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medicinal Chemicals and Botanical Products |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.0M | 111.4M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | JYNT | SEER |
|---|---|---|
| Price | $8.56 | $1.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | 47.1K | ★ 414.5K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $117,696,356.00 | $16,578,000.00 |
| Revenue This Year | $5.65 | $2.14 |
| Revenue Next Year | $3.86 | $25.90 |
| P/E Ratio | $72.38 | ★ N/A |
| Revenue Growth | 15.49 | ★ 16.99 |
| 52 Week Low | $7.50 | $1.62 |
| 52 Week High | $13.47 | $2.41 |
Technical Indicators
Market Signals| Indicator | JYNT | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 41.86 | 41.79 |
| Support Level | $8.56 | $1.77 |
| Resistance Level | $8.77 | $1.97 |
| Average True Range (ATR) | 0.39 | 0.10 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 42.50 | 23.86 |
Price Performance
Historical ComparisonAbout JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.